AB Science announces positive top-line results of final analysis from study AB10015 of masitinib in amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease
Primary analysis is a success and confirms interim analysis
Company to host webcast on masitinib in ALS
AB Science SA...
als
clinical
cure
data
death
disability
drugs
financial
free
lead
medicine
neurologist
paralysis
progression
research
riluzole
symptoms
test
tests
treatment
trial
tyrosine
update
urgent
website